{"id":"therapeutic-testosterone","safety":{"commonSideEffects":[{"rate":null,"effect":"Polycythemia (elevated red blood cell count)"},{"rate":null,"effect":"Gynecomastia (breast tissue enlargement)"},{"rate":null,"effect":"Acne"},{"rate":null,"effect":"Mood changes / aggression"},{"rate":null,"effect":"Fluid retention / edema"},{"rate":null,"effect":"Liver enzyme elevation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Testosterone is an androgenic steroid hormone that binds to androgen receptors throughout the body, promoting development and maintenance of male sexual characteristics, muscle mass, bone density, and metabolic function. In therapeutic contexts, exogenous testosterone is used to treat testosterone deficiency (hypogonadism) and restore normal endocrine function. The drug may also have immunomodulatory effects relevant to cancer treatment contexts, though this application is less common.","oneSentence":"Therapeutic testosterone replaces or supplements endogenous testosterone to restore normal hormonal levels and physiological function.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:12:20.660Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Testosterone deficiency (hypogonadism)"},{"name":"Potential supportive care in cancer patients with low testosterone"}]},"trialDetails":[{"nctId":"NCT05893069","phase":"PHASE4","title":"Oxandrolone Multiligament Knee","status":"SUSPENDED","sponsor":"George F. Hatch","startDate":"2023-07-01","conditions":"Ligament Tear Knee","enrollment":60},{"nctId":"NCT06096870","phase":"PHASE2","title":"Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-04-22","conditions":"Prostate Cancer, Recurrent Prostate Cancer, PET Positive","enrollment":65},{"nctId":"NCT06610968","phase":"NA","title":"Acute Vitamin D Supplementation on Testosterone in Females","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Southern California","startDate":"2025-07-01","conditions":"Female Hormone Profile","enrollment":20},{"nctId":"NCT00588185","phase":"NA","title":"[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2003-02","conditions":"Prostate Cancer","enrollment":300},{"nctId":"NCT05051293","phase":"","title":"Comparison of the Concentration of Estrogen and Testosterone Ratio in Male Patients With Cirrhosis and Hypotension","status":"WITHDRAWN","sponsor":"Methodist Health System","startDate":"2021-08-22","conditions":"Hypotension, Cirrhosis","enrollment":""},{"nctId":"NCT07481942","phase":"","title":"Body Composition Assessment in Transgender Population.","status":"COMPLETED","sponsor":"Celia Bañuls","startDate":"2017-01-01","conditions":"Transgender","enrollment":70},{"nctId":"NCT07476222","phase":"","title":"PREDICTORS OF TESTOSTERONE DECLINE IN MIDDLE-AGED MEN","status":"NOT_YET_RECRUITING","sponsor":"Andijan State Medical Institute","startDate":"2026-04-01","conditions":"Testosterone Deficiency, Androgen Deficiency, Male Hypogonadism","enrollment":800},{"nctId":"NCT03767244","phase":"PHASE3","title":"A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2019-06-11","conditions":"Prostatic Neoplasms","enrollment":2517},{"nctId":"NCT04675788","phase":"PHASE4","title":"Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening","status":"COMPLETED","sponsor":"Indiana University","startDate":"2021-09-02","conditions":"Long QT Syndrome, Abnormalities, Drug-Induced","enrollment":73},{"nctId":"NCT04798469","phase":"PHASE2","title":"Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2022-01-10","conditions":"Opioid Use, Pain, Hypogonadism, Male","enrollment":150},{"nctId":"NCT06998238","phase":"NA","title":"Evaluating the Influence of Diet-induced Weight Loss on Fat (Adipose) Tissue's Insulin Sensitivity and Testosterone Synthesis in Women With Overweight or Obesity, Insulin Resistance, and Hyperandrogenemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Missouri-Columbia","startDate":"2024-01-07","conditions":"Overweight and Obesity, Hyperandrogenemia, Insulin Resistance","enrollment":8},{"nctId":"NCT07476001","phase":"PHASE2","title":"Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2026-03","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":12},{"nctId":"NCT06075953","phase":"PHASE2","title":"DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment","status":"RECRUITING","sponsor":"QuantumLeap Healthcare Collaborative","startDate":"2024-02-17","conditions":"Ductal Carcinoma in Situ","enrollment":400},{"nctId":"NCT07460960","phase":"PHASE2","title":"TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men","status":"RECRUITING","sponsor":"Lomonosov Moscow State University Medical Research and Educational Center","startDate":"2026-03-05","conditions":"Erectile Dysfunction Due to Arterial Disease, Atheroscleroses, Erectile Disfunction","enrollment":150},{"nctId":"NCT05935761","phase":"PHASE2","title":"Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-06-01","conditions":"Chronic Low Back Pain","enrollment":108},{"nctId":"NCT07335796","phase":"PHASE2","title":"A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2026-01-09","conditions":"Prostate Cancer","enrollment":30},{"nctId":"NCT07463508","phase":"NA","title":"Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity","status":"RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2026-01-01","conditions":"Testicular Germ Cell Cancer","enrollment":20},{"nctId":"NCT07142551","phase":"PHASE2","title":"Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2026-03-09","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":60},{"nctId":"NCT05526248","phase":"PHASE2","title":"A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide","status":"COMPLETED","sponsor":"Bayer","startDate":"2022-12-19","conditions":"Biochemically Recurrent Prostate Cancer","enrollment":28},{"nctId":"NCT05787470","phase":"","title":"State of Hormones Impact Nociceptive Expression","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2023-03-01","conditions":"Pain, Gender Identity","enrollment":120},{"nctId":"NCT05964920","phase":"PHASE2, PHASE3","title":"Does Human Skeletal Muscle Possess an Epigenetic Memory of Testosterone?","status":"COMPLETED","sponsor":"Norwegian School of Sport Sciences","startDate":"2024-09-01","conditions":"Healthy Aging, Age-Related Sarcopenia, Testosterone Deficiency","enrollment":45},{"nctId":"NCT05726292","phase":"PHASE2","title":"A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2025-01-06","conditions":"Prostate Cancer, Prostate Adenocarcinoma","enrollment":90},{"nctId":"NCT07254429","phase":"PHASE2","title":"COMPASS - COpenhagen MenoPAuSe Study","status":"RECRUITING","sponsor":"Martin Blomberg Jensen","startDate":"2025-10-02","conditions":"Menopausal Osteoporosis, Bone Markers","enrollment":192},{"nctId":"NCT05617885","phase":"PHASE1","title":"Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Praful Ravi, MB BCHir, MRCP","startDate":"2023-08-09","conditions":"Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer","enrollment":9},{"nctId":"NCT07179952","phase":"PHASE2","title":"Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )","status":"NOT_YET_RECRUITING","sponsor":"Indiana University","startDate":"2027-01-01","conditions":"Asthma","enrollment":30},{"nctId":"NCT04104893","phase":"PHASE2","title":"A Study of CHeckpoint Inhibitors in Men With prOgressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2020-02-20","conditions":"Metastatic Castration Resistant Prostate Cancer","enrollment":40},{"nctId":"NCT05951452","phase":"","title":"The Developmental Origins of Endometriosis","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2024-01-08","conditions":"Endometriosis","enrollment":40},{"nctId":"NCT06855277","phase":"PHASE3","title":"Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-07-01","conditions":"Prostate Cancer","enrollment":940},{"nctId":"NCT07278362","phase":"PHASE4","title":"Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance","status":"NOT_YET_RECRUITING","sponsor":"University of Miami","startDate":"2026-05-31","conditions":"Prostate Cancer, Hypogonadism, Male","enrollment":35},{"nctId":"NCT06305598","phase":"PHASE1","title":"Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2024-12-19","conditions":"Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8","enrollment":14},{"nctId":"NCT04743466","phase":"","title":"Evaluation of Association Between Testosterone Levels, Dementia, and Adverse Mental Health Outcomes","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-02-13","conditions":"Anxiety Disorder, Depression, Genetic Disorder","enrollment":1},{"nctId":"NCT05894954","phase":"PHASE3","title":"Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment","status":"COMPLETED","sponsor":"Alzheimer's Prevention and Reversal Project, Inc.","startDate":"2023-07-31","conditions":"Mild Cognitive Impairment, Dementia, Mild","enrollment":73},{"nctId":"NCT06689085","phase":"PHASE3","title":"52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism","status":"RECRUITING","sponsor":"Halozyme Therapeutics","startDate":"2025-03-07","conditions":"Hypogonadism, Male","enrollment":100},{"nctId":"NCT07408440","phase":"NA","title":"Transdermal Testosterone Gel for Female Sexual Interest and Arousal Disorder in Peri- and Post Menopause","status":"NOT_YET_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2026-04-01","conditions":"Menopause, Sexual Dysfunction, Libido Disorder","enrollment":150},{"nctId":"NCT07143279","phase":"EARLY_PHASE1","title":"Testosterone Supplementation in Patients in Best Supportive Care: Impact on Quality of Life","status":"RECRUITING","sponsor":"Jules Bordet Institute","startDate":"2026-02-11","conditions":"Hypotestosteronism, Palliative Care","enrollment":20},{"nctId":"NCT04316650","phase":"NA","title":"Study of Maintenance of the Efficiency and Adverse Effects of Pharmacological Treatments in Sex Offenders With Paraphilia","status":"WITHDRAWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-06","conditions":"Paraphilia","enrollment":""},{"nctId":"NCT04558866","phase":"PHASE2","title":"Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Latin American Cooperative Oncology Group","startDate":"2021-06-09","conditions":"Prostate Cancer","enrollment":51},{"nctId":"NCT07407647","phase":"PHASE2","title":"Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer","status":"RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2026-03-01","conditions":"Anal Carcinoma, Cervical Carcinoma, Malignant Female Reproductive System Neoplasm","enrollment":25},{"nctId":"NCT04731376","phase":"PHASE1","title":"Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2021-01-25","conditions":"Hypogonadism, Malignant Urinary System Neoplasm, Urinary System Disorder","enrollment":56},{"nctId":"NCT07212712","phase":"NA","title":"The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in Humans","status":"NOT_YET_RECRUITING","sponsor":"University of British Columbia","startDate":"2026-04-01","conditions":"Cerebral Blood Flow, Cerebral Blood Flow Regulation, Sex Differences","enrollment":50},{"nctId":"NCT07397702","phase":"NA","title":"Effects of HIIT and MICT Training on Cardiorespiratory Fitness, Testosterone/Cortisol Ratio, and Mental Health in Young Adults","status":"NOT_YET_RECRUITING","sponsor":"Universidad de Colima","startDate":"2026-05-25","conditions":"Exercise","enrollment":76},{"nctId":"NCT02994602","phase":"PHASE1","title":"Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males","status":"COMPLETED","sponsor":"Kimberly Myer","startDate":"2017-01","conditions":"Healthy Men, Male Contraception, Healthy Women","enrollment":26},{"nctId":"NCT06733350","phase":"PHASE4","title":"Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance","status":"SUSPENDED","sponsor":"Roswell Park Cancer Institute","startDate":"2025-01-15","conditions":"Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8","enrollment":600},{"nctId":"NCT07393867","phase":"PHASE2","title":"Androgen-responsive POSLUMA-guided Intra-prostatic Boost","status":"NOT_YET_RECRUITING","sponsor":"Martin T. King, MD, PhD","startDate":"2026-03","conditions":"Intermediate Risk Prostate Cancer, High Risk Prostate Cancer, Prostate Cancer","enrollment":23},{"nctId":"NCT04455750","phase":"PHASE3","title":"A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2021-10-14","conditions":"Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8","enrollment":61},{"nctId":"NCT04729114","phase":"PHASE1","title":"A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer","status":"RECRUITING","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2021-06-14","conditions":"Prostate Cancer, Metastatic Castration Resistant Prostate Cancer, Metastatic Castration-sensitive Prostate Cancer","enrollment":174},{"nctId":"NCT06720597","phase":"NA","title":"EndoPAT Device for Endothelial Dysfunction in ED","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2025-08-13","conditions":"Erectile Dysfunction, Hypogonadism, Male, Endothelial Dysfunction","enrollment":120},{"nctId":"NCT07138222","phase":"","title":"IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma","status":"RECRUITING","sponsor":"Peter MacCallum Cancer Centre, Australia","startDate":"2025-09-11","conditions":"Melanoma (Skin Cancer)","enrollment":80},{"nctId":"NCT05498272","phase":"PHASE2","title":"Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations","status":"RECRUITING","sponsor":"Rana McKay, MD","startDate":"2023-02-01","conditions":"Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation","enrollment":32},{"nctId":"NCT07092527","phase":"PHASE4","title":"Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2025-12-05","conditions":"Transgenderism, Reproductive Issues","enrollment":80},{"nctId":"NCT06039371","phase":"PHASE2","title":"Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study","status":"RECRUITING","sponsor":"University of Washington","startDate":"2024-05-21","conditions":"Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8","enrollment":69},{"nctId":"NCT06059118","phase":"PHASE2","title":"Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2023-10-04","conditions":"Prostate Cancer","enrollment":50},{"nctId":"NCT07339436","phase":"NA","title":"Lower Body Plyometric Training Effects on Upper Body in Basketball Players","status":"COMPLETED","sponsor":"Birjand University of Medical Sciences","startDate":"2024-09-20","conditions":"Basketball Performance","enrollment":50},{"nctId":"NCT06072677","phase":"NA","title":"Adolescent Mood During Puberty and Testosterone","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2023-08-24","conditions":"Adolescent Depression","enrollment":60},{"nctId":"NCT07328789","phase":"","title":"Factors Influencing Cardiac Rehabilitation Success","status":"NOT_YET_RECRUITING","sponsor":"Pomeranian Medical University Szczecin","startDate":"2026-01-03","conditions":"Rehabilitation","enrollment":150},{"nctId":"NCT07328542","phase":"PHASE4","title":"Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men","status":"NOT_YET_RECRUITING","sponsor":"Azurity Pharmaceuticals","startDate":"2026-02","conditions":"Hypogonadism, Male","enrollment":144},{"nctId":"NCT06130449","phase":"EARLY_PHASE1","title":"Testosterone and Neural Function","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-04-01","conditions":"Spinal Cord Injury","enrollment":15},{"nctId":"NCT07329998","phase":"NA","title":"The Aim of the Study is to Check Whether Follicular Fluid Evaluation Using a Spectrophotometer Can Differentiate High Quality Oocytes From Low Quality Oocytes. Oocyte Quality Will be Defined Using GDF9, BMP15 and Oocyte Morphology.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hillel Yaffe Medical Center","startDate":"2024-09-22","conditions":"Oocyte Quality Assessment Using Spectrophotometer","enrollment":200},{"nctId":"NCT04439370","phase":"","title":"Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2019-10-01","conditions":"Hypertension, Menopause, Premature, Menopause","enrollment":160},{"nctId":"NCT07323329","phase":"PHASE2, PHASE3","title":"Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization","status":"RECRUITING","sponsor":"Beni-Suef University","startDate":"2025-10-10","conditions":"Infertility, Infertility (IVF Patients)","enrollment":165},{"nctId":"NCT06866119","phase":"","title":"Effects of Estrogen on Heart Health in Women With Primary Ovarian Insufficiency","status":"NOT_YET_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-03-01","conditions":"Primary Ovarian Insufficiency, Premature Menopause, Metabolic Complications","enrollment":45},{"nctId":"NCT07302451","phase":"PHASE2","title":"REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute, Naples","startDate":"2025-12-01","conditions":"Prostate Cancer (Adenocarcinoma)","enrollment":50},{"nctId":"NCT06084338","phase":"PHASE2","title":"Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-12-14","conditions":"Prostate Cancer","enrollment":60},{"nctId":"NCT06343870","phase":"PHASE3","title":"Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME)","status":"RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2025-12-18","conditions":"Menopause, Testosterone Deficiency, Estrogen Deficiency","enrollment":140},{"nctId":"NCT04895306","phase":"PHASE2","title":"Testosterone Replacement to Alleviate Pain in Postmenopausal Women (TRAPP Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2022-11-15","conditions":"Pain, Opioid Use, Androgen Deficiency","enrollment":40},{"nctId":"NCT03887936","phase":"PHASE4","title":"Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2019-10-01","conditions":"Type 2 Diabetes Mellitus, Hypogonadism","enrollment":92},{"nctId":"NCT07299292","phase":"PHASE2","title":"Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)","status":"RECRUITING","sponsor":"SMED Clinical Research","startDate":"2025-12-01","conditions":"Prostate Cancer (Diagnosis)","enrollment":60},{"nctId":"NCT05241860","phase":"PHASE2","title":"Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2022-11-21","conditions":"Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8","enrollment":79},{"nctId":"NCT07287800","phase":"PHASE1, PHASE2","title":"TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2025-07-01","conditions":"Hypogonadism, Male, End Stage Renal Disease (ESRD), Kidney Transplant","enrollment":50},{"nctId":"NCT04025372","phase":"PHASE2","title":"INTREPId (INTermediate Risk Erection PreservatIon Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2020-06-01","conditions":"Prostate Cancer","enrollment":234},{"nctId":"NCT05555680","phase":"","title":"Effect of Hyperandrogenism on IVF Outcomes in PCOS Patients","status":"TERMINATED","sponsor":"Clinique Ovo","startDate":"2022-01-21","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries","enrollment":32},{"nctId":"NCT04838249","phase":"","title":"Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System","status":"RECRUITING","sponsor":"University of Leipzig","startDate":"2021-05-05","conditions":"Transsexualism, Transgenderism, Adiposity","enrollment":80},{"nctId":"NCT05623397","phase":"","title":"A Deep Learning Method to Evaluate QT on Ribociclib","status":"COMPLETED","sponsor":"CMC Ambroise Paré","startDate":"2023-07-28","conditions":"Breast Cancer, Ribociclib","enrollment":70},{"nctId":"NCT03511196","phase":"EARLY_PHASE1","title":"Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2018-09-17","conditions":"Prostate Cancer, Stage IV Prostate Cancer, Advanced Prostate Cancer","enrollment":17},{"nctId":"NCT05914324","phase":"NA","title":"Outpatient Pediatric Pulse Oximeters in Africa","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-11-04","conditions":"Child, Infant, Respiratory Tract Infections","enrollment":1200},{"nctId":"NCT07260825","phase":"PHASE2, PHASE3","title":"Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"TriHealth Inc.","startDate":"2025-12","conditions":"Vulvodynia, Dyspareunia, Lichen Sclerosus of Vulva","enrollment":44},{"nctId":"NCT06594926","phase":"PHASE2","title":"Working Out M0 Bipolar Androgen Therapy","status":"RECRUITING","sponsor":"Australian and New Zealand Urogenital and Prostate Cancer Trials Group","startDate":"2024-08-14","conditions":"Prostate Cancer","enrollment":69},{"nctId":"NCT01961843","phase":"NA","title":"Abiraterone Acetate for Castrate Resistant Prostate Cancer","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2014-01-14","conditions":"Prostate Cancer","enrollment":40},{"nctId":"NCT07227740","phase":"","title":"Testosterone Deficiency and Endothelial Dysfunction After Spinal Cord Injury","status":"RECRUITING","sponsor":"Craig Hospital","startDate":"2025-07-15","conditions":"Spinal Cord Injuries, Endothelial Dysfunction, Testosterone Deficiency","enrollment":48},{"nctId":"NCT05669664","phase":"PHASE2","title":"Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-07-20","conditions":"Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma","enrollment":21},{"nctId":"NCT03734653","phase":"EARLY_PHASE1","title":"Testosterone Therapy in Castration Resistant Prostate Cancer","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2019-01-18","conditions":"Prostate Cancer, Castration-Resistant Prostate Cancer","enrollment":30},{"nctId":"NCT03648385","phase":"PHASE2","title":"Effects of DHEA in Pulmonary Hypertension","status":"COMPLETED","sponsor":"Rhode Island Hospital","startDate":"2019-01-09","conditions":"Pulmonary Arterial Hypertension","enrollment":26},{"nctId":"NCT04807894","phase":"PHASE4","title":"Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo","status":"RECRUITING","sponsor":"Maimonides Medical Center","startDate":"2020-11-01","conditions":"Recurrent Urinary Tract Infection, Vaginal Atrophy, Postmenopausal Disorder","enrollment":100},{"nctId":"NCT06100705","phase":"PHASE2","title":"Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC","status":"RECRUITING","sponsor":"Yale University","startDate":"2023-12-20","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":26},{"nctId":"NCT04812912","phase":"","title":"Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-03-18","conditions":"Colorectal Cancer, Colorectal Neoplasms, Colorectal Carcinoma","enrollment":120},{"nctId":"NCT05738213","phase":"NA","title":"Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2023-01-10","conditions":"Migraine","enrollment":100},{"nctId":"NCT03345576","phase":"PHASE2","title":"Testosterone and Long Pulse Stimulation After SCI","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2018-07-01","conditions":"Spinal Cord Injury","enrollment":12},{"nctId":"NCT03228732","phase":"EARLY_PHASE1","title":"The Effects of Fluoxetine and/or DHEA","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2017-12-19","conditions":"Type 1 Diabetes Mellitus","enrollment":60},{"nctId":"NCT06245681","phase":"","title":"Effects of Cross-sex Hormone Treatment on Cardiac Function, Myocardial and Hepatic Fat Content","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2017-10-20","conditions":"Gender Dysphoria","enrollment":40},{"nctId":"NCT04265053","phase":"EARLY_PHASE1","title":"Human Cerebral Blood Flow Regulation","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2021-04-12","conditions":"Cerebral Arterial Diseases","enrollment":110},{"nctId":"NCT04977765","phase":"","title":"Cardiometabolic Health in Transgender Males","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical College of Wisconsin","startDate":"2021-09-30","conditions":"Transgender, Transgenderism","enrollment":90},{"nctId":"NCT06824818","phase":"NA","title":"Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2026-06","conditions":"Elderly, Prostate Cancer","enrollment":155},{"nctId":"NCT03516812","phase":"PHASE2","title":"Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer","status":"COMPLETED","sponsor":"University of Washington","startDate":"2018-08-29","conditions":"Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma","enrollment":36},{"nctId":"NCT06291675","phase":"","title":"Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2023-03-03","conditions":"Gender Dysphoria, Hormone Therapy Induced Morphologic Change","enrollment":50},{"nctId":"NCT02703220","phase":"PHASE4","title":"Sleep Apnea in Elderly","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2015-07-03","conditions":"Sleep Apnea, Elderly Adults","enrollment":100},{"nctId":"NCT07187947","phase":"","title":"Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway","status":"RECRUITING","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2025-07-18","conditions":"Gender Incongruence, Cardiovascular (CV) Risk, Cardiovascular Disease Risk Factor","enrollment":500},{"nctId":"NCT03716739","phase":"PHASE2","title":"Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2019-03-19","conditions":"Prostate Cancer","enrollment":136},{"nctId":"NCT05081193","phase":"PHASE2","title":"Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2022-03-07","conditions":"Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer","enrollment":15},{"nctId":"NCT03576001","phase":"PHASE2","title":"Multimodality Intervention for Function and Metabolism in SCI","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2019-08-23","conditions":"Spinal Cord Injuries","enrollment":84},{"nctId":"NCT06922318","phase":"PHASE2","title":"The COSMYC Trial (COmbined Suppression of MYC)","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2025-08-19","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Mertestate","Testoderm","Testolin","Testosterone","Testostroval"],"phase":"marketed","status":"active","brandName":"therapeutic testosterone","genericName":"therapeutic testosterone","companyName":"Memorial Sloan Kettering Cancer Center","companyId":"memorial-sloan-kettering-cancer-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Therapeutic testosterone replaces or supplements endogenous testosterone to restore normal hormonal levels and physiological function. Used for Testosterone deficiency (hypogonadism), Potential supportive care in cancer patients with low testosterone.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}